发明名称 PODXL PROTEIN IN COLORECTAL CANCER
摘要 <p>The present disclosure provides a method for determining whether a mammalian subject having a colorectal cancer belongs to a first or a second group, wherein the prognosis of subjects of the first group is better than the prognosis of subjects of the second group, comprising the steps of: a) evaluating an amount of PODXL protein in at least part of a sample earlier obtained from the subject, and determining a sample value corresponding to the evaluated amount; b) comparing said sample value from step a) with a predetermined reference value; and if said sample value is higher than said reference value, c1) concluding that the subject belongs to said second group; and if said sample value is lower than or equal to said reference value, c2) concluding that the subject belongs to said first group. Related uses, means and a method of treatment are also provided.</p>
申请公布号 CA2775903(A1) 申请公布日期 2011.05.05
申请号 CA20102775903 申请日期 2010.10.26
申请人 ATLAS ANTIBODIES AB 发明人 JIRSTROEM, KARIN;UHLEN, MATHIAS;PONTEN, FREDRIK
分类号 G01N33/574;A61K39/00 主分类号 G01N33/574
代理机构 代理人
主权项
地址